RxDoctor Payments Data

Joann Nutter

Family · Pennsboro, WVNPI 1568568210

Payments from drug & device makers

$1,386in general payments, 2019–2025

Across 81 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$659
  • AbbVie$176
  • Mylan Specialty L.p.$71
  • Shield Therapeutics Inc$65
  • Sanofi-aventis U.S. LLC$55
  • Lilly USA, LLC$50
  • plus $310 from 11 others

What the payments were for

  • Food & beverage$1,386100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,386 in reported general payments places this provider in the 70th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Medicare billing

Part B allowed, 2024
$62,785
Medicare patients
166
Services billed
1,227

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide59$106,693
OzempicSemaglutide52$89,932
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$49,469
FarxigaDapagliflozin Propanediol38$42,378
Breztri AerosphereBudesonide/Glycopyr/Formoterol36$41,167
TrulicityDulaglutide20$36,398
EliquisApixaban25$33,324
JanuviaSitagliptin Phosphate20$28,720
JardianceEmpagliflozin15$21,058
TradjentaLinagliptin13$18,249
VascepaIcosapent Ethyl23$16,995
Tresiba Flextouch U-100Insulin Degludec22$7,124
SymbicortBudesonide/Formoterol Fumarate12$6,383
Albuterol Sulfate HfaAlbuterol Sulfate171$6,351
Atorvastatin Calcium429$4,083

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$50$143,09179 claims
Novo NordiskOzempic$40$89,93252 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$659$89,92886 claims
GSKTrelegy Ellipta$16$49,46937 claims
Boehringer IngelheimJardiance, Tradjenta$11$39,30728 claims
AbbVieSynthroid$176$3,47534 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,507 family providers in West Virginia.

Other family in Pennsboro

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →